Buscar
Mostrando ítems 1-10 de 11
Biological and conformational evaluation of angiotensin II lactam bridge containing analogues
(Elsevier B.V., 2011-12-10)
Angiotensin II (All) is the active octapeptide product of the renin enzymatic cascade, which is responsible for sustaining blood pressure. in an attempt to establish the All-receptor-bound conformation of this octapeptide, ...
The Importance of Ring Size and Position for the Antiplasmodial Activity of Angiotensin II Restricted Analogs
(Springer, 2014-09-01)
Malaria is caused by the protozoa Plasmodium and is responsible for approximately one million deaths annually. the antimalarial effects of angiotensin II and its analogs against Plasmodium gallinaceum and falciparum have ...
A study of the anti-plasmodium activity of angiotensin II analogs
(John Wiley & SonsChichester, 2013-09)
Controlling the dissemination of malaria requires the development of new drugs against its etiological agent, a protozoan of the Plasmodium genus. Angiotensin II and its analog peptides exhibit activity against the development ...
Relação estrutura-atividade da galanina e de alguns de seus análogos
(Universidade Federal de São Paulo (UNIFESP), 2009-04-29)
Galanin (Gal1-29-NH2) is a 29-amino-acid neuropeptide (GWTLNSAKGLLGPHAID NHRSFHDKYGLA-NH2) which was originally isolated from the porcine gut. Gal1-29-NH2 has been involved in multiple physiological functions including ...
Antimicrobial Susceptibility Testing for Enterococci
(2022)
Enterococci are major, recalcitrant nosocomial pathogens with a wide repertoire of intrinsic and acquired resistance determinants and the potential of developing resistance to all clinically available antimicrobials. As ...
Farmacocinética poblacional en el manejo empírico de infecciones en pacientes con neoplasias hematológicas y neutropenia febril pos-quimioterapia
(Universidad Nacional de ColombiaBogotá - Ciencias - Maestría en Ciencias - FarmacologíaDepartamento de FarmaciaFacultad de CienciasBogotá, ColombiaUniversidad Nacional de Colombia - Sede Bogotá, 2021)
Los pacientes con neoplasias hematológicas y neutropenia febril postquimioterapia podrían presentar alteraciones fisiológicas que lleven a cambios en la farmacocinética (PK) de los fármacos comparado a individuos sin cáncer ...